FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology, and may be used to treat viral ocular diseases. That is ensured by the interferon (INF) status assay, namely evaluating alpha-INF production, gamma-INF production, serum INF titre, spontaneous INF in the reaction in vitro. The derived data collection and the presence of clinical manifestations enable stating the viral diseases thereby choosing the therapeutic approach.
EFFECT: invention enables normalising the interferon status in the patients with the viral ophthalmic diseases.
4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SELECTING THERAPY OF CHRONIC INFLAMMATORY DISEASES OF EYE SURFACE BASED ON CONTROLLED POTENTIATION OF EXUDATIVE REACTION BY MEANS OF MECHANICAL OR IMMUNE IMPACT | 2009 |
|
RU2421193C2 |
METHOD FOR TREATING THE CASES OF DRY EYE SYNDROME | 2005 |
|
RU2290923C2 |
METHOD FOR DETECTING INDICATIONS FOR INTERFERONOTHERAPY IN CASE OF OPHTHALMOHERPES | 2004 |
|
RU2258224C1 |
METHOD FOR PROPHYLAXIS OF COMPLICATION IN HERPES VIRAL INFECTION IN CORNEA DAMAGE | 2003 |
|
RU2230566C1 |
TREATMENT METHOD FOR CHRONIC CORNEA EROSIONS OF HERPETIC ETHIOLOGY | 2017 |
|
RU2653260C1 |
EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS | 2018 |
|
RU2692087C1 |
GEL-LIKE EYE DROPS FOR TREATMENT OF INFLAMMATORY ALLERGIC, BACTERIAL, VIRAL, TRAUMATIC AND DYSTROPHIC EYE DISEASES | 2014 |
|
RU2561046C1 |
EYE GEL DROPS FOR TREATMENT OF INFLAMMATORY, VIRUS, BACTERIAL, ALLERGIC, METABOLIC, TRAUMATIC DISEASES | 2017 |
|
RU2688687C1 |
METHOD OF TREATING INFLAMMATIONS OF ANTERIOR EYE SEGMENT | 2013 |
|
RU2513597C1 |
AGENT FOR TREATMENT OF DRY EYE SYNDROME AS COMPLICATION AFTER OPHTHALMIC INFECTION | 2003 |
|
RU2239436C1 |
Authors
Dates
2013-10-10—Published
2012-07-06—Filed